AOP |
Adverse outcome pathway |
BPA |
Bisphenol A |
DDT |
Dichlorodiphenyltrichloroethane |
DEHP |
Bis(2-ethylhexyl) phthalate |
DES |
Diethylstilbestrol |
DHEA(S) |
Dehydroepiandrosterone(-sulfate) |
EATS |
Estrogen-androgen-thyroid-steroidogenesis |
EDC |
Endocrine disrupting chemical |
FREIA |
“Female Reproductive toxicity of EDCs: a human evidence-based screening and Identification Approach” |
FSH |
Follicle stimulating hormone |
GnRH |
Gonadotropin-releasing hormone |
GPER |
G-coupled protein oestrogen receptor |
HP(A)G axis |
Hypothalamic-pituitary-(adrenal)-gonadal axis |
IATA |
Integrated approach to testing and assessment |
LH |
Luteinizing hormone |
OECD |
Organisation for Economic Cooperation and Development |
PCOS |
Polycystic ovary syndrome |
POF |
Premature ovarian failure |
POI |
Primary ovarian insufficiency |
REACH |
Registration, Evaluation, Authorisation and restriction of CHemicals |
TG |
Test guideline |